Serum interferon-α levels and IFN type I-stimulated genes score perform equally to assess systemic lupus erythematosus disease activity

Affiliations

• ¹ Sorbonne Université, Inserm, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, Département d'Immunologie, Paris, France francois.chasset@gmail.com.
• ² Sorbonne Université, Faculté de Médecine, Assistance Publique-Hôpitaux de Paris, Service de Dermatologie et Allergologie, Hôpital Tenon, F-75020 Paris, France.
• ³ Department of Pathology and Immunology, Centre Médical Universitaire, School of Medicine, Geneva, Switzerland.
• ⁴ Sorbonne Université, Inserm, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, Département d'Immunologie, Paris, France.
• ⁵ Sorbonne université, Faculté de médecine, Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Paris, France.
• ⁶ Division of Immunology and Allergy, University Hospital Center of Lausanne, Lausanne, Switzerland.
• ⁷ Clinical Immunology, Department of Biomedicine, University Hospital Basel, Basel, Switzerland.
• ⁸ Division of Internal Medicine, University Hospital Basel, Basel, Switzerland.
• ⁹ Division of Nephrology and Hypertension, University Hospital Bern, Bern, Switzerland.
• ¹⁰ Laboratory of Clinical Immunology and Allergy, University Hospital and School of Medicine, Geneva, Switzerland.
• ¹¹ Division of Clinical Epidemiology, University of Geneva, Geneva, Switzerland.